Mellett Paul J's Form 4 filing
Enanta Pharmaceuticals Inc (ENTA) · filed Feb 13, 2023
- Accession no.
- 0001062993-23-002936
- Filed
- Feb 13, 2023
- Trade date
- Feb 9, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $268.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mellett Paul JCIK 0001185034 | Officer (Treasurer and CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 9, 2023 | Common Stock | SSaleDisposed | −4,200 | $53.64 | −$225,288 | 84,263 | Direct | |
| Feb 9, 2023 | Common Stock | SSaleDisposed | −800 | $54.41 | −$43,528 | 83,463 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.